Literature DB >> 12730609

7,12-Dimethylbenz[a]anthracene-induced bone marrow toxicity is p53-dependent.

Todd J Page1, Scott O'Brien, Karrie Holston, Peter S MacWilliams, Colin R Jefcoate, Charles J Czuprynski.   

Abstract

Polycyclic aromatic hydrocarbons (PAHs) are known immunotoxins and carcinogens. Our laboratory and others have demonstrated that metabolism of these compounds by CYP1B1 is required for carcinogenicity and immunotoxicity to occur. Previously, our laboratory reported significantly decreased bone marrow cellularity in mice following 7,12-dimethlybenz[a]anthracene (DMBA) administration. In addition, we have observed that DMBA causes apoptosis via activation of both caspase-8 and -9 in pre-B cells co-cultured with bone marrow stromal cells in vitro. In this study, we investigated the importance of the p53 protein in the bone marrow response to DMBA. Through the use of p53 gene knockout mice, we demonstrated that the effect of DMBA on bone marrow cellularity is p53-dependent. In addition, apoptosis of primary cultures of progenitor B cells cultured with bone marrow stromal cells and DMBA is also p53-dependent. The results of this study provide evidence for the importance of p53 in the signaling pathways by which PAHs cause immunotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730609     DOI: 10.1093/toxsci/kfg115

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  8 in total

1.  Proximal events in 7,12-dimethylbenz[a]anthracene-induced, stromal cell-dependent bone marrow B cell apoptosis: stromal cell-B cell communication and apoptosis signaling.

Authors:  Jessica E Teague; Heui-Young Ryu; Michael Kirber; David H Sherr; Jennifer J Schlezinger
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

2.  Analysis of dibenzo[def,p]chrysene-deoxyadenosine adducts in wild-type and cytochrome P450 1b1 knockout mice using stable-isotope dilution UHPLC-MS/MS.

Authors:  Tod A Harper; Jeff Morré; Fredine T Lauer; Tammie J McQuistan; Jessica M Hummel; Scott W Burchiel; David E Williams
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2015-03-12       Impact factor: 2.873

3.  Bone marrow lymphoid and myeloid progenitor cells are suppressed in 7,12-dimethylbenz(a)anthracene (DMBA) treated mice.

Authors:  A U N'jai; M Larsen; L Shi; C R Jefcoate; C J Czuprynski
Journal:  Toxicology       Date:  2010-02-18       Impact factor: 4.221

4.  Differential induction of CYP1A1 and CYP1B1 by benzo[a]pyrene in oral squamous cell carcinoma cell lines and by tobacco smoking in oral mucosa.

Authors:  Angela C Chi; Kathryn Appleton; Joel B Henriod; Joe W Krayer; Nicole M Marlow; Dipankar Bandyopadhyay; Ryan C Sigmon; David T Kurtz
Journal:  Oral Oncol       Date:  2009-07-02       Impact factor: 5.337

5.  CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation.

Authors:  Yeo-Jung Kwon; Hyoung-Seok Baek; Dong-Jin Ye; Sangyun Shin; Donghak Kim; Young-Jin Chun
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

6.  Cyp1b1-mediated suppression of lymphoid progenitors in bone marrow by polycyclic aromatic hydrocarbons coordinately impacts spleen and thymus: a selective role for the Ah Receptor.

Authors:  Michele Campaigne Larsen; Alhaji U N'Jai; David L Alexander; Catherine M Rondelli; E C Forsberg; Charles J Czuprynski; Colin R Jefcoate
Journal:  Pharmacol Res Perspect       Date:  2016-07-29

Review 7.  Spiritual Health in Nursing From the Viewpoint of Islam.

Authors:  Abbas Heydari; Fatemeh Khorashadizadeh; Fatemeh Heshmati Nabavi; Seyed Reza Mazlom; Mahdi Ebrahimi
Journal:  Iran Red Crescent Med J       Date:  2016-04-30       Impact factor: 0.611

Review 8.  Nano-selenium and its nanomedicine applications: a critical review.

Authors:  Bozena Hosnedlova; Marta Kepinska; Sylvie Skalickova; Carlos Fernandez; Branislav Ruttkay-Nedecky; Qiuming Peng; Mojmir Baron; Magdalena Melcova; Radka Opatrilova; Jarmila Zidkova; Geir Bjørklund; Jiri Sochor; Rene Kizek
Journal:  Int J Nanomedicine       Date:  2018-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.